VYNE Therapeutics Inc Live Stock Price Today, Share Analysis and Chart

Name: VYNE Therapeutics Inc: Is Infosys Ltd. worth buying?
Item: VYNE Therapeutics Inc
Rating: 1.13708325
Author: Trendlyne DVM scores

about

VYNE Therapeutics Inc is a biopharmaceutical company focused on developing proprietary, innovative and differentiated therapies for the treatment of immuno-inflammatory conditions. Its advanced product candidate is FMX114, which is being evaluated fo...

0.30 -0.01 (-3.23%)

93.02% Fall from 52W High

2.6M

XNAS Volume

XNAS 19 Sep, 2025 5:30 PM (EDT)

Not Eligible

Expensive Valuation

21.8 / 100

Technically Bearish

23.7 / 100

1Yr Price target upside is 1233%

2 analysts

VYNE Therapeutics Inc Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

VYNE Therapeutics Inc Live Stock Price Today, Share Analysis and Chart

VYNE Therapeutics Inc is a biopharmaceutical company focused on developing proprietary, innovative and differentiated therapies for the treatment of immuno-inflammatory conditions. Its advanced product candidate is FMX114, which is being evaluated fo...

93.02% Fall from 52W High

SWOT Analysis

VYNE Therapeutics Inc Live Price Chart